Talis Biomedical Co. (NASDAQ:TLIS – Get Free Report)’s stock price fell 18.3% during mid-day trading on Wednesday . The company traded as low as $1.43 and last traded at $1.43. 196 shares were traded during mid-day trading, a decline of 93% from the average session volume of 2,744 shares. The stock had previously closed at $1.75.
Talis Biomedical Price Performance
The stock has a market capitalization of $2.61 million, a price-to-earnings ratio of -0.05 and a beta of 1.30. The business has a 50 day simple moving average of $1.52 and a 200-day simple moving average of $1.63.
Talis Biomedical Company Profile
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.
Read More
- Five stocks we like better than Talis Biomedical
- Options Trading – Understanding Strike Price
- Top 3 Bank Stocks to Watch as Fed Rate Cuts Loom
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Uber and Tesla Surge on Robotaxis, Analyst Touts Texas Rides
- Consumer Discretionary Stocks Explained
- ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside
Receive News & Ratings for Talis Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talis Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.